Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis.

IF 0.9 Q4 RHEUMATOLOGY Modern rheumatology case reports Pub Date : 2024-04-10 DOI:10.1093/mrcr/rxae020
Masaki Shimomura, Yuka Okura, Yutaka Takahashi, Ichiro Kobayashi
{"title":"Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis.","authors":"Masaki Shimomura, Yuka Okura, Yutaka Takahashi, Ichiro Kobayashi","doi":"10.1093/mrcr/rxae020","DOIUrl":null,"url":null,"abstract":"We report a 9-year-old Japanese girl with chronic non-bacterial osteomyelitis (CNO) accompanied by recurrent erythema nodosum (EN) which was successfully treated with salazosulfapyridine (SASP). She was referred to our hospital because of recurrent erythema on her lower extremities and persistent knee and ankle arthralgia, which had been present for approximately one year. Although naproxen, a nonsteroidal anti-inflammatory drug (NSAID), was initiated, her symptoms frequently recurred. Magnetic resonance imaging demonstrated multiple distinct high-intensity signals in the talus bones suggestive of multiple bone edemas. Additionally, a histological examination of erythematous lesions was consistent with the histopathological findings of EN. She was diagnosed as having CNO complicated by EN, and received 250 mg/day of SASP as a second-line treatment, which showed partial response of both skin and bone lesions. Following increase in the dose of SASP to 500 mg/day resulted in complete remission of her skin and bone lesions. In conclusion, our findings suggest that SASP is effective not only for CNO bone lesions but also for EN. SASP could serve as a second-line therapeutic option at least for some cases of CNO complicated by EN refractory to NSAIDs.","PeriodicalId":94146,"journal":{"name":"Modern rheumatology case reports","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern rheumatology case reports","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1093/mrcr/rxae020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We report a 9-year-old Japanese girl with chronic non-bacterial osteomyelitis (CNO) accompanied by recurrent erythema nodosum (EN) which was successfully treated with salazosulfapyridine (SASP). She was referred to our hospital because of recurrent erythema on her lower extremities and persistent knee and ankle arthralgia, which had been present for approximately one year. Although naproxen, a nonsteroidal anti-inflammatory drug (NSAID), was initiated, her symptoms frequently recurred. Magnetic resonance imaging demonstrated multiple distinct high-intensity signals in the talus bones suggestive of multiple bone edemas. Additionally, a histological examination of erythematous lesions was consistent with the histopathological findings of EN. She was diagnosed as having CNO complicated by EN, and received 250 mg/day of SASP as a second-line treatment, which showed partial response of both skin and bone lesions. Following increase in the dose of SASP to 500 mg/day resulted in complete remission of her skin and bone lesions. In conclusion, our findings suggest that SASP is effective not only for CNO bone lesions but also for EN. SASP could serve as a second-line therapeutic option at least for some cases of CNO complicated by EN refractory to NSAIDs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用柳氮磺吡啶成功治疗一名 9 岁慢性非细菌性骨髓炎患者的结节性红斑。
我们报告了一名患有慢性非细菌性骨髓炎(CNO)并伴有复发性结节性红斑(EN)的 9 岁日本女孩的病例,她在接受柳氮磺吡啶(SASP)治疗后获得了成功。她因下肢反复出现红斑以及持续的膝关节和踝关节疼痛而被转诊至我院,这种情况已持续了约一年。虽然开始服用非甾体抗炎药(NSAID)萘普生,但她的症状经常复发。磁共振成像显示,距骨上有多个明显的高强度信号,提示多发性骨水肿。此外,红斑病灶的组织学检查结果与 EN 的组织病理学结果一致。她被诊断为 CNO 并发 EN,并接受了每天 250 毫克的 SASP 作为二线治疗,结果显示皮肤和骨骼病变均有部分反应。将 SASP 的剂量增加到 500 毫克/天后,她的皮肤和骨骼病变完全缓解。总之,我们的研究结果表明,SASP 不仅对 CNO 骨损有效,而且对 EN 也有效。SASP至少可作为非甾体抗炎药难治的某些CNO并发EN病例的二线治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
期刊最新文献
Symptomatic Pachydermodactyly: A Case Report. Mid-term outcomes of distal tibial oblique osteotomy in patients with rheumatoid arthritis: a report of three cases. Anaphylaxis and prolonged allergic reactions caused by intra-articular injection of diclofenac etalhyaluronate in knee osteoarthritis: A case report. Granulomatosis with polyangiitis with lacrimal gland enlargement and pancreatic swelling: case report and literature review. Isolated central nervous system lymphomatoid granulomatosis in an older adult patient with systematic lupus erythematosus: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1